|
|
iX Biopharma Ltd
SES •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/15/2026 10:04
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSES
Market Capitalization420.3 mln
Float606 mln
Earnings Date08/21/2026
Key Fundamentals
EPS-0.01
ROE-223
RPS0.01
ROIC-48.47
ROA-44.32
EBITDA, mln-4.99
EV / EBITDA-81.19
EV / EBIT-75.67
Revenue, mln7.23
EV / Revenue56.10
Financial Strength
Altman Z-Score5.96
Piotroski F-Score
3
/ 9
Beneish M-Score-5.43
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-6.1% |
7
/ 100
 |
| 1 Month |
-9.41% |
8
/ 100
|
| 2 Months |
126% |
97
/ 100
 |
| 6 Months |
206% |
97
/ 100
|
| 1 Year |
1825% |
100
/ 100
 |
|
| |
